Enlitisa (shanghai) Pharmaceutical Co., Ltd.

This phase II study tested an injectable drug called TISA-818-Inj in 57 adults with acute respiratory distress syndrome (ARDS), a severe lung condition. Participants received either a low dose, a high dose, or a placebo for 14 days. The main goal was to check safety, with seconda…

This early-stage trial tested the safety and tolerability of a new drug, UP-818-CC, in 73 healthy Chinese volunteers. Participants received either a single dose or multiple daily doses of the drug or a placebo. The main goal was to check for side effects and measure how the drug …

This early-stage study tested the safety of a new drug called TISA-818 in 49 healthy adults. Participants received either the drug or a placebo as a single shot or daily shots for a week. The goal was to check for side effects and how the drug moves through the body, not to treat…